Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v2-FR
Language French French
Date Updated 2021-03-29 2020-06-08
Drug Identification Number 02239944 02239944
Brand name KETOROLAC TROMETHAMINE INJECTION USP KETOROLAC TROMETHAMINE INJECTION USP
Common or Proper name KETOROLAC TROMETHAMINE INJECTION USP KETOROLAC TROMETHAMINE INJECTION USP
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE
Strength(s) 30MG 30MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 ML 1 ML
ATC code M01AB M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-06-05 2020-06-05
Estimated end date 2021-04-23 2021-02-26
Actual end date 2021-03-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments